IMAC (NASDAQ:IMAC) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS

IMAC (NASDAQ:IMACGet Rating) issued its earnings results on Friday. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by ($0.03), MarketWatch Earnings reports. IMAC had a negative return on equity of 41.54% and a negative net margin of 73.27%.

IMAC traded up $0.03 on Friday, hitting $0.83. The company had a trading volume of 367,404 shares, compared to its average volume of 155,668. IMAC has a 12-month low of $0.75 and a 12-month high of $2.75. The business’s fifty day simple moving average is $0.91 and its 200 day simple moving average is $1.12. The company has a market cap of $21.99 million, a PE ratio of -3.19 and a beta of -1.36. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.01.

A hedge fund recently raised its stake in IMAC stock. Geode Capital Management LLC lifted its position in IMAC Holdings, Inc. (NASDAQ:IMACGet Rating) by 14.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 195,643 shares of the company’s stock after purchasing an additional 24,559 shares during the period. Geode Capital Management LLC owned 0.77% of IMAC worth $289,000 at the end of the most recent quarter. Institutional investors own 24.27% of the company’s stock.

About IMAC (Get Rating)

IMAC Holdings, Inc owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains.

Read More

Earnings History for IMAC (NASDAQ:IMAC)

Receive News & Ratings for IMAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAC and related companies with MarketBeat.com's FREE daily email newsletter.